TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study
Clinical trial NCT01860456 · COMPLETED
Trial details
- NCT number
- NCT01860456
- Sponsor
- University of Pisa
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-05-01
- Primary completion
- 2024-12-31
- Enrollment
- 412
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.